title: Successful treatment of secondary NK/T-cell lymphoma of the testis.
authors.forename: Takashi
authors.initials: T
authors.lastname: Kobayashi
authors.forename: Akira
authors.initials: A
authors.lastname: Hangaishi
authors.forename: Go
authors.initials: G
authors.lastname: Yamamoto
authors.forename: Akihito
authors.initials: A
authors.lastname: Shinohara
authors.forename: Teppei
authors.initials: T
authors.lastname: Morikawa
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Takazawa
authors.forename: Satoshi
authors.initials: S
authors.lastname: Ota
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Imai
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Nakamura
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D016190:Carboplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D054391:Lymphoma, Extranodal NK-T-Cell / Q000473:pathology / Q000628:therapy*; D008297:Male; D009669:Nose Neoplasms / Q000188:drug therapy; D009919:Orchiectomy; D012074:Remission Induction; D012867:Skin / Q000473:pathology; D013736:Testicular Neoplasms / Q000556:secondary* / Q000628:therapy; D013737:Testis / Q000473:pathology
chemical_list: D005047:Etoposide; D003907:Dexamethasone; D016190:Carboplatin; D007069:Ifosfamide